If you or someone you love has been diagnosed with cancer, two questions immediately come to mind: "Where can I go for the best treatment?" and "What are my options?"
The motivation behind this publication is to provide you with answers to these and other important questions about cancer care in your local community. You may not know that for hundreds of area residents, Doylestown Hospital is the center of choice for advanced cancer services. Our Cancer Program offers patients and families state-of-the-art technology, access to the latest drug trials, and seamless, compassionate care from diagnosis to treatment to follow-up, in a setting convenient to home. Doylestown Hospital is emerging as one of the regional leaders in complete cancer care, with treatment options comparable to a university hospital.
The convenience of being treated locally is immeasurable, but ultimately, the goal of every cancer patient is a positive outcome. In that area, too, Doylestown Hospital is a proven leader; our cancer survival outcomes are comparable or above national standards. At Doylestown Hospital, we provide the very best cancer care in a responsive, healing environment that includes:
Advanced diagnostics including PET and MRI
Access to clinical trials
State-of-the-art radiation therapies including IMRT and BAT
Bracheytherapy for prostate cancer
Stereotactic breast biopsy for breast cancer diagnosis
5 Year Survival Rate
The Cancer Program at Doylestown Hospital takes a comprehensive and integrated approach to treating cancer. From the day of diagnosis through treatment and follow-up care, our medical staff and cancer team work to create a special plan of care. Our cancer team includes oncologists, radiologists, radiation oncologists, surgeons, pathologists, and appropriate sub-specialists who help patients choose which treatment modalities are right for them.
Our overall 5 year survival statistics suggest that heightened community awareness, along with effective screening and early detection, contributes to a large proportion of patients who present with stage 0 or stage 1 disease, a time when most cancers are highly curable.